이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Equasens Société anonyme 관리
관리 기준 확인 2/4
Equasens Société anonyme's CEO는 Denis Supplisson, Apr2022 에 임명되었습니다 의 임기는 2.25 년입니다. 는 € 560.82 가치에 해당하는 회사 주식의 0% 직접 소유합니다. 560.82. 경영진과 이사회의 평균 재임 기간은 각각 1.5 년과 12.6 년입니다.
주요 정보
Denis Supplisson
최고 경영자
n/a
총 보상
| CEO 급여 비율 | n/a |
| CEO 임기 | 2.4yrs |
| CEO 소유권 | 0.00007% |
| 경영진 평균 재임 기간 | 1.7yrs |
| 이사회 평균 재임 기간 | 12.8yrs |
최근 관리 업데이트
Recent updates
Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?
Sep 28
Equasens Société anonyme's (EPA:EQS) Intrinsic Value Is Potentially 75% Above Its Share Price
Jul 15Equasens Société anonyme's (EPA:EQS) Upcoming Dividend Will Be Larger Than Last Year's
Jun 22Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?
Jun 07Equasens Société anonyme (EPA:EQS) Is Aiming To Keep Up Its Impressive Returns
Apr 03At €51.10, Is It Time To Put Equasens Société anonyme (EPA:EQS) On Your Watch List?
Mar 08Some Confidence Is Lacking In Equasens Société anonyme's (EPA:EQS) P/E
Feb 14Estimating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Jan 27Should You Investigate Equasens Société anonyme (EPA:EQS) At €59.70?
Nov 29These 4 Measures Indicate That Equasens Société anonyme (EPA:EQS) Is Using Debt Safely
Oct 28A Look At The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Sep 27Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?
Aug 05Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.15
Jun 11Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year
May 22Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year
May 08What Does Equasens Société anonyme's (EPA:EQS) Share Price Indicate?
Apr 04Equasens Société anonyme (EPA:EQS) Will Want To Turn Around Its Return Trends
Feb 13Calculating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Jan 26At €71.60, Is Equasens Société anonyme (EPA:EQS) Worth Looking At Closely?
Dec 21Should You Be Adding Equasens Société anonyme (EPA:EQS) To Your Watchlist Today?
Dec 07Here's What's Concerning About Equasens Société anonyme's (EPA:EQS) Returns On Capital
Nov 12Is Equasens Société anonyme (EPA:EQS) Trading At A 26% Discount?
Oct 27Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?
Oct 12When Should You Buy Equasens Société anonyme (EPA:EQS)?
Sep 09With EPS Growth And More, Equasens Société anonyme (EPA:EQS) Makes An Interesting Case
Aug 24Equasens Société anonyme (EPA:EQS) Might Be Having Difficulty Using Its Capital Effectively
Jul 28Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.05
Jun 10Pharmagest Interactive (EPA:PHA) Has Announced That It Will Be Increasing Its Dividend To €1.05
May 27Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?
May 22Here's What Pharmagest Interactive's (EPA:PHA) Strong Returns On Capital Mean
Apr 25Are Investors Undervaluing Pharmagest Interactive SA (EPA:PHA) By 28%?
Feb 23Here's Why I Think Pharmagest Interactive (EPA:PHA) Might Deserve Your Attention Today
Feb 09Is Pharmagest Interactive SA (EPA:PHA) Potentially Undervalued?
Jan 25Many Would Be Envious Of Pharmagest Interactive's (EPA:PHA) Excellent Returns On Capital
Jan 06Pharmagest Interactive (EPA:PHA) Could Easily Take On More Debt
Nov 14Is There An Opportunity With Pharmagest Interactive SA's (EPA:PHA) 20% Undervaluation?
Oct 30Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?
Sep 28Is Pharmagest Interactive SA (EPA:PHA) Trading At A 20% Discount?
Jul 18Pharmagest Interactive (EPA:PHA) Will Want To Turn Around Its Return Trends
Jun 24Does Pharmagest Interactive (EPA:PHA) Deserve A Spot On Your Watchlist?
Apr 08Pharmagest Interactive SA (EPA:PHA) Is An Attractive Dividend Stock - Here's Why
Mar 24Pharmagest Interactive SA's (EPA:PHA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 03Our Take On The Returns On Capital At Pharmagest Interactive (EPA:PHA)
Feb 09
Shareholders of Pharmagest Interactive (EPA:PHA) Must Be Delighted With Their 500% Total Return
Jan 12What To Know Before Buying Pharmagest Interactive SA (EPA:PHA) For Its Dividend
Dec 15Are Strong Financial Prospects The Force That Is Driving The Momentum In Pharmagest Interactive SA's EPA:PHA) Stock?
Dec 01CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | €47m |
| Jun 30 2023 | n/a | n/a | €48m |
| Mar 31 2023 | n/a | n/a | €47m |
| Dec 31 2022 | €400k | €176k | €46m |
| Jun 30 2022 | n/a | n/a | €42m |
| Mar 31 2022 | n/a | n/a | €41m |
| Dec 31 2021 | €353k | €133k | €39m |
| Sep 30 2021 | n/a | n/a | €37m |
| Jun 30 2021 | n/a | n/a | €35m |
| Mar 31 2021 | n/a | n/a | €33m |
| Dec 31 2020 | €371k | €133k | €31m |
| Sep 30 2020 | n/a | n/a | €29m |
| Jun 30 2020 | n/a | n/a | €27m |
| Mar 31 2020 | n/a | n/a | €27m |
| Dec 31 2019 | €225k | €133k | €27m |
| Sep 30 2019 | n/a | n/a | €27m |
| Jun 30 2019 | n/a | n/a | €26m |
| Mar 31 2019 | n/a | n/a | €26m |
| Dec 31 2018 | €208k | €128k | €25m |
| Sep 30 2018 | n/a | n/a | €25m |
| Jun 30 2018 | n/a | n/a | €24m |
| Mar 31 2018 | n/a | n/a | €24m |
| Dec 31 2017 | €189k | €114k | €23m |
보상 대 시장: French 시장에서 비슷한 규모의 회사에 비해 Denis 의 총 보상이 합리적인지 여부를 입증하기에는 데이터가 부족합니다.
보상과 수익: Denis 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Denis Supplisson (55 yo)
2.4yrs
테뉴어
€400,201
보상
Mr. Denis Supplisson serves as Chief Executive Officer at Pharmagest Interactive SA since April 22, 2022. He served as Deputy Managing Director/Deputy Chief Executive Officer & Manager of the Europe Pharma...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Founder & Chairman of the Board | 14.7yrs | 데이터 없음 | 0.036% € 274.4k | |
| Deputy CEO | 4.2yrs | €428.66k | 0.000070% € 538.7 | |
| Chief Executive Officer & Director | 2.4yrs | €400.20k | 0.000070% € 538.7 | |
| Director | no data | €330.17k | 0.16% € 1.2m | |
| Group Chief Administrative & Financial Officer | 1.7yrs | 데이터 없음 | 데이터 없음 | |
| Head of Communications | less than a year | 데이터 없음 | 데이터 없음 | |
| Chief Human Resources Officer | 4.9yrs | 데이터 없음 | 데이터 없음 | |
| Head of the Medical Solutions Division | less than a year | 데이터 없음 | 데이터 없음 | |
| Deputy MD & Head of the Pharmagest Division | less than a year | 데이터 없음 | 데이터 없음 |
1.7yrs
평균 재임 기간
55yo
평균 연령
경험이 풍부한 관리: EQS 의 관리팀은 경험 (평균 재직 기간 1.4 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Founder & Chairman of the Board | 14.7yrs | 데이터 없음 | 0.036% € 274.4k | |
| Deputy CEO | 4.2yrs | €428.66k | 0.000070% € 538.7 | |
| Chief Executive Officer & Director | 11.7yrs | €400.20k | 0.000070% € 538.7 | |
| Director | 15.3yrs | €330.17k | 0.16% € 1.2m | |
| Director | 22.3yrs | €6.91k | 0.0033% € 25.6k | |
| Director | 13.7yrs | 데이터 없음 | 데이터 없음 | |
| Director | 13.7yrs | €7.07k | 0.0027% € 21.2k | |
| Director | 13.3yrs | 데이터 없음 | 0.0046% € 35.3k | |
| Independent Director | 12.3yrs | €6.76k | 0.00017% € 1.3k | |
| Independent Director | 7.3yrs | €6.91k | 0.00013% € 1.0k | |
| Director | 7.3yrs | €604.00 | 0.00011% € 846.6 | |
| Independent Director | 1.3yrs | 데이터 없음 | 0.000010% € 77.0 |
12.8yrs
평균 재임 기간
57.5yo
평균 연령
경험이 풍부한 이사회: EQS 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 12.5 년).